Hybio Pharmaceutical (300199) — Cash Flow Quality Index
Hybio Pharmaceutical (300199) has a Cash Flow Quality Index of 1.54x as of June 2025. Operating cash flow of CN¥116.72 Million exceeds net income of CN¥75.60 Million, indicating high earnings quality where cash backs reported profits. Explore Hybio Pharmaceutical debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hybio Pharmaceutical Cash Flow Quality Index (2008–2021)
Historical Cash Flow Quality Index for Hybio Pharmaceutical across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Hybio Pharmaceutical.
Annual Cash Flow Quality Index for Hybio Pharmaceutical (2008–2021)
Year-by-year earnings quality comparison for Hybio Pharmaceutical.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 5.52x | CN¥156.83 Million | CN¥28.44 Million | ▲ +750.8% |
| 2017 | 0.65x | CN¥213.74 Million | CN¥329.72 Million | ▼ -36.2% |
| 2016 | 1.02x | CN¥296.41 Million | CN¥291.92 Million | ▲ +123.3% |
| 2015 | 0.45x | CN¥138.84 Million | CN¥305.34 Million | ▼ -49.2% |
| 2014 | 0.89x | CN¥153.43 Million | CN¥171.56 Million | ▼ -24.3% |
| 2013 | 1.18x | CN¥153.48 Million | CN¥129.93 Million | ▲ +21.7% |
| 2012 | 0.97x | CN¥87.19 Million | CN¥89.80 Million | ▲ +7.8% |
| 2011 | 0.90x | CN¥72.48 Million | CN¥80.47 Million | ▼ -13.0% |
| 2010 | 1.03x | CN¥54.69 Million | CN¥52.85 Million | ▲ +40.2% |
| 2009 | 0.74x | CN¥26.11 Million | CN¥35.37 Million | ▼ -68.0% |
| 2008 | 2.30x | CN¥45.75 Million | CN¥19.86 Million | — |